Yune Kunes

Yune Kunes

Company: Prime Medicine

Job title: Vice President Analytical Development and QC

Seminars:

Navigating Characterization Strategies in Cell Therapy Development with Evolving Insights from FDA Guidance 11:00 am

In the rapidly advancing field of cell therapy, developers face significant challenges in characterizing their products to meet regulatory standards. The FDA has provided evolving guidance on what is required for effective characterization, which includes understanding product attributes, ensuring consistency, and demonstrating safety and efficacy. Join us to: Understand how cell therapy developers are adapting…Read more

day: Workshop C - Analytical Development

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.